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Abstract
Background: In the vascular system, Notch receptors and ligands are expressed mainly on
arteries, with Delta-like 4 (Dll4) being the only ligand known to be expressed early during the
development of arterial endothelial cells and capillaries. Dll4  null embryos die very early in
development with severely reduced arterial calibre and lumen and loss of arterial cell identity.
Results: The current detailed analysis of these mutants shows that the arterial defect precedes the
initiation of blood flow and that the arterial Dll4-/- endothelial cells proliferate and migrate more
actively. Dll4-/- mutants reveal a defective basement membrane around the forming aorta and
increased endothelial cell migration from the dorsal aorta to peripheral regions, which constitute
the main causes of arterial lumen reduction in these embryos. The increased proliferation and
migration of Dll4-/- endothelial cells was found to coincide with increased expression of the
receptors VEGFR-2 and Robo4 and with downregulation of the TGF-β accessory receptor
Endoglin.
Conclusion: Together, these results strongly suggest that Notch signalling can increase arterial
stability and calibre by decreasing the response of arterial endothelial cells to local gradients of pro-
angiogenic factors like VEGF.
Background
The initial steps of embryonic blood vessel formation
(vasculogenesis) involve differentiation and aggregation
of mesodermal-derived endothelial precursors (angiob-
lasts) to generate the primary vascular plexus. Blood ves-
sels then grow and remodel into a mature network of
hierarchically organized vessels, in a process designated as
angiogenesis. During this remodelling, endothelial vessels
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differentiate into arteries and veins, grow, sprout, split
and fuse according to a combination of autocrine signal-
ling and cues provided by other tissues of the embryo [1].
The formation of the initial vascular plexus is highly
dependent on vascular endothelial growth factor (VEGF-
A) and its receptors, VEGFR-1 and VEGFR-2, since mouse
embryos lacking these genes display very early vascular
defects and die between 8.5–9.5 dpc [2-4]. Notably, VEGF
haploinsufficiency causes embryonic lethality. VEGFR-2 is
thought to be the major mediator of the VEGF signalling
since VEGFR-2-/- embryos fail to form blood islands or
organized blood vessels [3], whereas VEGFR-1-/- embryos
form blood vessels with an excess of endothelial and hae-
mangioblast progenitors [4,5]. Furthermore, deletion of
the VEGFR-1 tyrosine kinase domain does not affect vas-
cular development [6]. In some contexts VEGFR-1 seems
to work as a biological sink to VEGF, antagonizing
VEGFR-2 mediated signalling [7,8]. Through activation of
VEGFR-2, VEGF induces phosphorylation of several pro-
teins which in turn regulate endothelial cell permeability,
proliferation, migration and survival. During later vessel
remodelling, other ligands become increasingly impor-
tant and the disruption of the signalling induced by angi-
opoietins, ephrins, TGF-β, slits or netrins causes specific
vascular defects that often leads to early embryonic death
[9,10].
The Notch pathway is also involved in the regulation of
vascular development as the single gene deletion of
Notch1 or combined deletion of Notch1 and Notch4 results
in severe defects in early arterial development [11]. The
Notch receptors can bind five known ligands from the
Delta (Dll1, Dll3 and Dll4) and Jagged (Jagged1 and
Jagged2) families. The Dll4 ligand is the only canonical
Notch ligand strongly expressed in arterial endothelial
cells at early stages of development [11,12]. Beside VEGF,
Dll4 is the only other known vascular-related haploinsuf-
ficient lethal gene, indicating how critical its dosage levels
are for vascular development [13-15]. We have previously
shown that the majority of the Dll4+/- embryos die at 10.5
dpc in the CD1 genetic background, whereas all the Dll4-/
- embryos die at 9.5 dpc with severely reduced dorsal aor-
tae. Furthermore, Dll4-/- aortic endothelial cells lose the
expression of the arterial-specific genes Efnb2 and Gja4
(Cx37), and ectopically express the vein marker Ephb4,
one of the receptors for the arterial ephrinB2 ligand [15].
In order to understand the cause of this arterial calibre and
lumen reduction, a stepwise analysis of the early vascular
development of Dll4-/- embryos was carried out.
Methods
Mice
All procedures complied with the standards for care and
use of animal subjects as stated in the Guide for the Care
and Use of Laboratory Animals (Institute of Laboratory
Animal Resources, National Academy of Sciences of the
U.S.A.) and were approved by the institutional committee
for the ethical use of laboratory animals of the Faculdade
Medicina Veterinaria (project POCTI 48677). Embryos
were obtained by the intercross of Dll4+/- mice in the CD1
genetic background as described previously [15]. These
heterozygous mice were kept in the CD1 genetic back-
ground due to the higher lethal haploinsufficiency in the
other tested genetic backgrounds (almost 100%). The
embryonic age was initially determined by the date of the
formation of the copulation plug and confirmed by the
number of somites.
X-Gal staining, immunofluorescence and in situ 
hybridization
Whole-mount immunohistochemistry and X-gal staining
were carried out by standard techniques [16]. For sections,
after fixation in 4% paraformaldehyde (PFA), embryos
were cryoprotected in 15% sucrose, embedded in 7.5%
gelatine and cryosectioned at 12 μm. Antibodies against
PECAM-1 (Pharmingen), α SMA (Sigma), SM22α
(Abcam), β-catenin (Sigma), Fibronectin (Sigma), Endog-
lin (Pharmingen), Laminin (Abcam) and CollagenIV
(Chemicon) were used as primary antibodies and species-
specific conjugated to Alexa Fluor (Molecular Probes)
were used as secondary antibodies.
In situ hybridization of cryostat sections with digoxigenin
labelled riboprobes Dll4 (full-length); Flk1 [17]; Flt1 [4];
Notch1  (a 2168 bp BamHI-EcoRV fragment of the
NM_008714 cDNA clone, starting at nucleotide 4205 and
ending at nucleotide 6373); Hey1 [18], VEGFA [19], was
essentially done as previously described [20]. After over-
night incubation with anti-Dig-AP (1:2000, Roche) the
signal was developed with Fast Red solution (Roche) or
BM purple (Roche). The double in situ hybridization was
done with the Dll4 riboprobe labelled with fluorescein
and the Notch1 with digoxigenin. For the amplification of
the  Dll4  signal was used the anti-Fluo-POD (1:100,
Roche) and the FITC-tyramide from the TSA-Plus Fluores-
cein System (Perkin Elmer). The Notch1 signal was devel-
oped after the Dll4  signal as for the single in situ
hybridizations. Fluorescence images were acquired on a
Leica DM5000B microscope (sections) or an Olympus
SZX12 stereomicroscope (wholemount). Confocal images
were acquired using a Leica Spectral AOBS microscope. All
the images were processed on Adobe Photoshop 9.0.
BrdU and TUNEL labelling
BrdU labelling was achieved by a 2 hour BrdU pulse (100
ug BrdU/g body weight, intraperitoneally) before fixation
in 4% PFA. Cryosections from the fixed embryos were
treated in 50% formamide/1 × SSC, pH = 7 for 1 hour at
65°C and HCl (7.5%) for 30 minutes at 37°C and incu-
bated overnight with mouse anti-BRDU (1:1000, Sigma).BMC Developmental Biology 2008, 8:117 http://www.biomedcentral.com/1471-213X/8/117
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To visualize the nucleus a15 minute incubation in DAPI
solution followed by a brief fixation in 4% PFA was per-
formed before the DNA denaturation. Endothelial anti-
PECAM-1 immunostaining was performed also before the
BrdU immunostaining. In this experiment we used con-
secutive cryosections from all the anterior-middle region
of the embryos (2 embryos from each genotype). From
each cryosection a 3 channel picture was taken and used
to score the number of total and proliferating aortic
endothelial cells.
To detect apoptotic endothelial cells on cryosections, anti-
PECAM-1 and DAPI staining after TUNEL labelling and
staining with the fluorescein in situ cell death detection it
(Roche) was performed. Cell counting was carried out as
described for the BrdU staining.
Quantitative PCR
Total RNA was extracted from whole embryos, after
removal of the yolk sac, with the RNeasy Mini Kit (Qia-
gen). cDNA synthesis was done using the Superscript III
First Strand Synthesis kit (Invitrogen). In two different
experiments embryos were obtained from two different
litters (n = 4 for each genotype). In each experiment, for
each analysed gene, 6 separate real time PCR (RT-PCR)
reactions were carried out, in triplicates, using SYBR Green
Mixes and ABI PRISM 7300 (Applied Biosystems). Gene
expression was normalised to  -actin. Used Primer
sequences are as follows:  -actin  5'-TGTTACCAACT-
GGGACGACA-3'and 5'-GGGGTGTTGAAGGTCTCAAA-
3';VEGFR2  5'-GGCGGTGGTGACAGTATCTT-3' and 5'-
GAGGCGATGAATGGTGATCT-3'  VEGFR1  5'-GAC-
CCTCTTTTGGCTCCTTC-3'and 5'-CAGTCTCTCCCGT-
GCAAACT-3' ; VEGFA 5'-GGAGAGCAGAAGTCCCATGA-
3' and 5'-ACACAGGACGGCTTGAAGAT-3'; Hey1 5-CAC-
CTGAAAATGCTGCACAC-3' and 5'-ATGCTCAGATAACG-
GGCAAC-3';  Hey2 5'-TGCCAAGTTAGAAAAGGCTGA-3'
and 5'-CACTCTCGGAATCCAATGCT-3'; Cx37  5'-ACG-
GTCGTCCCCTCTACCT-3' and 5'-GTCGAGTGTTCCT-
GGACCTG-3'; Endoglin 5'-CACACCTCCCAAGGACACAT-
3' and 5'-TGGAGTCCCAGAAAGTCAGG-3'; Robo4  5'-
CGAGGACGCCATTCTAAAAC-3' and 5'-CCAATCCCAGC
CGACTACTA-3' and PECAM 5'-GTGGTCATCGCCACCT-
TAAT-3' and 5'-GGCTTCCACACTA GGCTCAG-3'.
Results
Reduced arterial calibre in Dll4-/- embryos is determined 
before the onset of blood flow and is not caused by defects 
in angioblast differentiation
The Dll4 gene starts to be expressed in the embryo at the
2-somite stage in the endothelium of the developing heart
and dorsal aortae [15]. As the development of the dorsal
aortae is coincident with heart development and the initi-
ation of blood flow, we asked if the early arterial calibre
and lumen reduction seen in the Dll4-/- embryos could be
related to impaired haemodynamic forces, which are
known to influence arterial identity and remodelling [21].
Confocal imaging of the dorsal aortae of 8-somite stage
(ss) embryos shows that in Dll4-/- embryos the arterial cal-
ibre and lumen is already significantly reduced before the
initiation of heart beat and blood flow, which begins
around 10–11 ss (Fig. 1A, B). Together with previous
observations [22], these results suggest that the initial reg-
ulation of blood vessel size is an intrinsic property of early
endothelial cells.
The reduction of the arterial calibre could arise from either
defects in the maturation of the dorsal aorta once formed
or from abnormal differentiation and impaired migration
of angioblasts from the lateral plate mesoderm to the mid-
line of the embryo. Angioblasts are endothelial progeni-
tors and express high levels of VEGFR-2 and no detectable
levels of PECAM-1 [22]. In situ hybridization with probes
for the Notch1 and Dll4 mRNAs shows that Dll4 is not
expressed in cells from the lateral plate mesoderm, where
angioblasts (VEGFR-2+/PECAM-) are located (Fig. 1C, D, E
and 1F), and only becomes expressed after initiation of
aorta formation. This indicates that the reduction of the
arterial calibre observed in the Dll4-/-  embryos is not
caused by defects in early angioblast differentiation or
migration to the midline, since Dll4 is only expressed at
the aortic endothelium at this stage.
Dll4-/- arterial endothelial cells display abnormal 
morphology and a defective basement membrane
To study the nature of Dll4-/- endothelial cell phnotype we
analysed endothelial morphology and extracellular
matrix integrity in embryos with 8–11 somites, the stage
immediately before the onset of circulation and when the
phenotype starts to become more pronounced. The anal-
ysis of transverse sections labelled with the endothelial
marker PECAM-1 revealed that the Dll4-/- aortic endothe-
lial cells, in the anterior and middle region of the embryo,
are frequently more aggregated and do not acquire a spin-
dle-like shape (Fig. 2A, B and 2C). The majority of these
cells display a rounder morphology which is characteristic
of incompletely differentiated or loosely attached
endothelial cells. Interestingly, fibronectin, laminin and
collagenIV immunostaining further revealed that these
cells have a severely defective basement membrane in
both the anterior and posterior (presomitic) dorsal aortae
(Fig. 2G-T). Whereas in a normal developing dorsal aorta
there is accumulation of a thick layer of surrounding
fibronectin, in the Dll4-/- embryos the endothelial matrix
is very irregular and some of the arterial endothelial cells
are not in direct contact with it. These defects occur both
in the anterior and presomitic domains of the dorsal aor-
tae, whereas the arterial calibre reduction occurs only in
the anterior domain. This suggests that the defects
observed in basement membrane integrity are not suffi-BMC Developmental Biology 2008, 8:117 http://www.biomedcentral.com/1471-213X/8/117
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cient to explain the reduction in the arterial calibre seen in
the Dll4-/- embryos.
Dll4-/- aortic defects precede smooth muscle development
Besides the formation of the basement membrane,
another biological process that confers stability and cohe-
sion to the developing arteries is the recruitment of peri-
cytes and smooth muscle cells. Immunostaining for alpha
smooth muscle actin (αSMA) (Fig. 2D) and in situ hybrid-
ization for Pdgfrb (data not shown) on Dll4+/+ embryonic
sections at this developmental stage, showed that there is
virtually no differentiated smooth muscle cells or peri-
cytes associated with the endothelium of these primordial
arteries. To further investigate a possible function of Dll4
in arterial smooth muscle cell recruitment we did imunos-
taining for Sm22α a gene highly expressed by neural crest
derived smooth muscle cells and progenitors. We detected
Sm22α in several cells surrounding the control and
mutant aortic endothelium but just some Sm22α positive
cells were found immediately adjacent and adherent to
the aortic endothelial cells (Fig. 2E, F). Most of the mural
cells Sm22α+ in contact with the endothelial cells showed
a round shape and were not completely attached to it. In
fact we detected less Sm22α+ cells in contact with the Dll4-
/- aortas, although this can be related to the reduced arte-
rial calibre and available endothelial cell surface. We also
analysed Sm22α staining in the pre-somitic region, where
Dll4-/- and control aortae have a similar calibre, but at this
level we could not observe Sm22α+ cells surrounding the
aorta of either control or mutant embryos. These results
suggest that the arterial phenotypic consequences of Dll4
loss of function precede the existence of fully differenti-
ated supporting cells in the arteries.
Loss of the Notch ligand Dll4 increases endothelial cell 
proliferation and migration
To further characterize the Dll4-/- endothelial cell behav-
iour we analysed the in vivo proliferation and migration of
endothelial cells. To detect the primary defect the analysis
of the aortic endothelial cell number and proliferation
rate was done with Dll4+/+ and  Dll4-/- embryos with 8
somites. Each embryo was serially sectioned and immu-
nostained for PECAM-1 and BrdU. At this early stage of
development there are 28% less endothelial cells in the
Dll4-/- aortae compared to the control dorsal aortae (Fig.
3A), and as development proceeds this difference
The dorsal aortae calibre and lumen reduction in the Dll4-/- embryos is not caused by blood flow or angioblast defects Figure 1
The dorsal aortae calibre and lumen reduction in the Dll4-/- embryos is not caused by blood flow or angioblast 
defects. (A, B) Confocal imaging analysis of 8 ss Dll4+/+ and Dll4-/- embryos showing in red the dorsal aortae (da) endothelial 
cells (labelled with anti-PECAM-1) and in blue all the other cells from the adjacent tissues (labelled with anti-β-catenin). (C-F) 
Anti-PECAM-1 or fluorescent in situ hybridization on consecutive cryosections from a Dll4+/+ 8 ss embryo, showing that 
VEGFR-2 and Notch1 are expressed in the endothelial cells (PECAM-1+) and in the mesoderm cells from the lateral plate 
(green arrows), where angioblasts arise. The Dll4 mRNA is not detected on the angioblasts or on the primordial anterior car-
dinal vein (white arrowheads) but only on aortic endothelial cells (white arrows). (Scale Bars: 15 μm).BMC Developmental Biology 2008, 8:117 http://www.biomedcentral.com/1471-213X/8/117
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The Dll4-/- arterial endothelial cells have an abnormal morphology, become more aggregated and display a defective basement  membrane Figure 2
The Dll4-/- arterial endothelial cells have an abnormal morphology, become more aggregated and display a 
defective basement membrane. (A-C) Anti-PECAM-1 staining of 8 ss embryo cryosections showing the morphology of 
Dll4+/+ and Dll4-/- dorsal aortae endothelial cells. The white stars label the DAPI stained endothelial nuclei. Dll4-/- endothelial 
cells are more aggregated and fail to develop a stretched spindle-like form which leads to a reduced (B) or absent aortic lumen 
(C). (D) Anti-PECAM-1 (red) and anti-αSMA (green) staining of 16 ss cryosection of a Dll4+/+ embryo showing the absence of 
arterial (a) and venous (v) endothelium associated smooth muscle cells. Note the strong αSMA staining in the endoderm (e) 
and pericardium (p). (E, F) Both control and mutant dorsal aortae (a) are surrounded by neural crest derived smooth muscle 
cell progenitors with high amounts of Sm22α protein (in green). (G-R) Anti-PECAM-1 (red), anti-fibronectin (green) and DAPI 
(blue) staining of cryosections from the anterior (G-L) and posterior (M-R) region of 11 ss Dll4+/+ and Dll4-/- embryos. Figures 
I-L and O-R are close ups of the upper left dorsal aortae and show the defective basement membrane (green) in both the 
anterior and posterior regions of the Dll4-/- aortae. In the mutants many endothelial cells are not in direct contact with the 
underlying, fibronectin-rich, extracelular matrix (arrows). (S, T) At this stage of development the aortic (a) basement mem-
brane is relatively poor in laminin (S, control) and collagenIV (T, control) when compared with fibronectin (J and P). The 
reduced Dll4-/- dorsal aortae have even less and more irregular laminin and collagenIV coverage. (Scale Bars: 30 μm).BMC Developmental Biology 2008, 8:117 http://www.biomedcentral.com/1471-213X/8/117
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becomes more pronounced (data not shown). Unexpect-
edly, however, the proliferation rate of aortic Dll4-/-
endothelial cells is almost two-fold higher (Fig. 3B, D).
This apparent contradiction could be explained by either
increased apoptosis or increased outward migration of the
aortic Dll4-/- endothelial cells. To test the first hypothesis,
we performed TUNEL analysis, which showed that
although there is an increase of endothelial cell apoptosis,
its rate is too low to counterbalance the increase in
endothelial cell proliferation (Fig. 3C).
The sequential analysis of the intersomitic vessel develop-
ment from 10 to 14 ss embryos showed that Dll4-/- aortic
endothelial cells migrate earlier and faster through the
intersomitic space and accumulate in excessive numbers
in the region of dorsal anastomotic vessel formation (Fig.
3E–J). Every time a somite forms in the posterior region a
new gradient of angiogenic factors is established within
the newly formed intersomitic space boundaries, which
attracts the endothelial cells. Therefore, the migration of
Dll4-/- endothelial cells is more advanced in the first than
in the last somites. Consequently, the mutant dorsal aor-
tae calibre is also much more reduced in the anterior
somites and increases gradually until the most posterior
somites and presomitic mesoderm, where its calibre is
normal (Fig. 3J). To further investigate how these embry-
onic tissues regulate this gradual endothelial cell migra-
tion, we performed in situ hybridization with a probe to
the VEGF-A mRNA on embryonic sections. In the anterior
and middle regions of the embryo, the neural tube and
the endoderm express high levels of VEGF-A, but in the
presomitic mesoderm, where dorsal aortae do not sprout,
VEGF-A mRNA was only detected in the endoderm, close
to the dorsal aortae (Fig. 3M, N). This indicates that the
neural tube, and not only the somites, can be a regulator
of intersomitic vessel sprouting and dorsal growth. The
results suggest that in the absence of angiogenic gradients
secreted by the somites and the neural tube (as in the pre-
somitic mesoderm), the Dll4-/- endothelial cells remain
associated with the dorsal aortae and form a normal arte-
rial lumen, even though they have a defective basement
membrane as described above.
This increased migration of arterial endothelial cells also
occurs towards the region of the developing limb bud,
where an accumulation of Dll4-lacZ + endothelial cells can
be seen (Fig. 3I, J). In the anterior asomitic region of the
embryo there is also an increased accumulation of
endothelial cells in a dorsal region where the primordial
anterior cardinal vein arises and develops. Confocal anal-
ysis shows increased but restricted sprouting of endothe-
lial cells from the dorsal aortae, since we did not observe
further extension and somite invasion of these sprouts
(Fig. 3K, L). Altogether, these results suggest that the dor-
sal aortae calibre and lumen reduction seen in the Dll4-/-
embryos is mainly caused by the increased outward
migration of the endothelial cells from the central dorsal
aortae to peripheral regions of the embryo. As Dll4 is not
expressed in non-vascular tissues at these stages of devel-
opment, the observed phenotype suggests a specific
increase of endothelial cell response to normal angiogenic
attractant gradients produced by surrounding tissues.
Venous localization of the Dll4-/- "arterial" endothelial 
cells
One of the distinguishable features of mammalian arterial
and venous early development is that the venous angiob-
lasts migrate and form the initial anterior cardinal vein in
a dorsal position close to the neural tube, whereas arterial
angioblasts form the dorsal aortae ventrally and close to
the endoderm. Little is known about the molecular mech-
anisms that regulate this early segregation of arterial and
venous lineages. In the Dll4-/- embryos we can follow the
migration of arterial endothelial cells by analysis of lacZ
expression, because the β-galactosidase protein is very sta-
ble. In the anterior, asomitic region, of the Dll4-/- embryos
abnormal migration of "arterial" endothelial cells to the
region where the primordial anterior cardinal veins form
was very frequently observed (Fig. 4A–D). This migration
is frequently associated with arterial-venous fusions (Fig.
4G, H) and an increase of the pool of venous endothelial
cells. At later stages, in the middle (somitic) region of the
embryo, almost all arterial endothelial cells localize
dorso-laterally to the neural tube and not ventrally as in
the wild-type embryo (Fig. 4E, F). The observed migration
and delocalization of the arterial Dll4-/- endothelial cells
to the dorsal and venous region can be related with the
incomplete differentiation of the "arterial" endothelial
cells and abnormal increased responsiveness to the ang-
iogenic factors produced by the neural tube. Alternatively,
these cells can be less sensitive to the existing repulsive
factors. We previously showed that these Dll4-/- "arterial"
endothelial cells express the vein marker Ephb4 and fail to
express detectable levels of the arterial marker Efnb2. So
these uncommitted "arterial" endothelial cells may
respond to the distribution of the gradients like the
venous angioblasts or endothelial cells.
Arterial Dll4-/- endothelial cells express more VEGFR-2 and 
Robo4 and less Endoglin
To better understand the molecular mechanisms that can
be at the origin of this abnormal behaviour of the Dll4-/-
endothelial cells we performed quantitative RT-PCR for
several known early angiogenesis regulator genes. The
analysis was done with total RNA extracted from 11 ss
embryos. This stage was selected because the effects of the
mutation and defective blood flow in remodelling are just
starting and the expression of known arterial markers is
increased comparative to earlier stages. The use of total
RNA from the embryos limited our ability to determineBMC Developmental Biology 2008, 8:117 http://www.biomedcentral.com/1471-213X/8/117
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Increased proliferation, sprouting and migration of Dll4-/- arterial endothelial cells Figure 3
Increased proliferation, sprouting and migration of Dll4-/- arterial endothelial cells. (A-C) Quantification of the 
endothelial cell number per aortic section (A), percentage of proliferating endothelial cells (B), and percentage of apoptotic 
endothelial cells (C) in the aortae of 8ss Wt and Dll4-/- embryos (n=2 for each genotype, 30 sections per embryo). (D) Repre-
sentative images of the sections used for quantification. Endothelial cells are shown in red (anti-PECAM-1), nuclei in blue 
(DAPI) and proliferating cells in green (anti-BRDU). The proliferating endothelial cells are also indicated (arrows). (E-J) 
Whole-mount embryos labelled with anti-PECAM-1 (E-H, green) or X-gal (I, J) showing the increased migration of intersomitic 
vessel (isv) Dll4-/- endothelial cells. (E, F) Confocal imaging of the somitic region of 10ss embryos showing that in Dll4-/- embryos 
(F) the aortae endothelial cells invade the intersomitic space earlier and migrate extensively, causing the calibre reduction of 
the dorsal aortae (da). (G, H) At 12ss the endothelial cells start to accumulate in the dorsal domain (arrows) of the Dll4-/- 
embryos. (I, J) The X-gal staining of 14ss embryos shows the accumulation of endothelial cells (blue) in the dorsal region of the 
Dll4-/- first anterior-middle somites (J), forming a large dorsal vessel (dv). The Dll4-/- cells also migrate extensively to the primor-
dial limb buds (lb). (K, L) Confocal imaging of 14ss wholemount embryos labelled with anti-PECAM-1. The Dll4-/- dorsal aortae 
(da) are thinner and show extensive sprouting (red dots). (M, N) In situ hybridization for VEGF mRNA on cryosections of a 
12ss embryo shows that in the anterior region (M), VEGF is expressed by both the neural tube (nt) and endoderm (e) cells, but 
in the posterior (pre-somitic) region (N) is only expressed by the endoderm cells. Error bars indicate s.e.m. (Scale Bars: D, 
25mm; E-J, 150mm; K-N, 100μm).BMC Developmental Biology 2008, 8:117 http://www.biomedcentral.com/1471-213X/8/117
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the expression changes specifically within endothelial
cells. The results show a 41% increase in the VEGFR-2
expression level in the Dll4-/- embryos and no significant
variation of VEGFR-1 expression. In addition, Robo4 was
upregulated by 56% and Endoglin downregulated by 41%
(Fig. 5A). As the Dll4 gene is only expressed in the embry-
onic arteries, whereas VEGFR-2, Robo4 and Endoglin are
also expressed in angioblasts and venous endothelial cells
[17,23-25], this difference could be even more significant
if RNA from only arterial endothelial cells had been used.
The PECAM-1 expression level was used as a control of the
endothelial fraction in the samples and Cx37, a known
arterial specific marker, was used as a control of arterial
differentiation. Its expression is reduced almost four-fold
in the Dll4-/- embryos. As expected, the canonical Notch
effectors Hey1 and Hey2 are also downregulated in the
mutants. The reduction in the expression level is probably
not higher because these two genes are also expressed in
other non-endothelial tissues. By in situ hybridization on
Dll4-/- sections we did not detect Hey1 mRNA in the arte-
rial endothelial cells (Fig. 6I). On the other hand, the lev-
els of expression of Tie-2 and VE-cadherin genes showed
no significant differences between wild-type and Dll4-/-
embryos (data not shown).
Since these qRT-PCR results represent differences in whole
embryo expression levels, in situ hybridization with a
probe for the VEGFR-2 mRNA on wild-type and Dll4-/-
embryos was carried out. In wild-type and heterozygous
embryos the VEGFR-2 gene was found to be more strongly
expressed in the venous endothelium than in the arterial
endothelial cells, where the Dll4 gene is strongly expressed
(Fig. 5B, C). Interestingly, in the Dll4-/-  embryos the
expression level of VEGFR-2 in arterial endothelial cells is
higher and similar to its expression in veins (Fig. 5D). In
situ  hybridization for VEGFR-1 and imunostaining for
endoglin was carried out without detection of any clear
difference between Dll4+/+  and  Dll4-/-  aortae. Together
these results show that, in relation to their wild-type coun-
terparts,  Dll4-/- endothelial cells express more VEGFR-2
and Robo4, both of which are involved in the regulation of
endothelial cell proliferation and migration [23,26-28]
and express less the TGF-β accessory receptor endoglin,
which when ablated in vitro increases endothelial cell pro-
liferation [29] and in vivo decreases arterial stability and
smooth muscle cell recruitment [30].
Notch-Dll4 signalling in developing arteries does not occur 
through lateral inhibition
Notch signalling, in most cellular processes studied so far,
functions through lateral inhibition, where a Notch signal
receiving cell upregulates the expression of the Hes/Hey
genes and downregulates the expression of Delta. This cell
can no longer activate the pathway in neighbouring cells
Dll4-/- endothelial cells migrate dorsally towards the neural tube, fusing with developing anterior cardinal veins Figure 4
Dll4-/- endothelial cells migrate dorsally towards the neural tube, fusing with developing anterior cardinal veins. 
X-gal (A-F) and anti-PECAM-1 (G, H) staining of cryosections from the anterior (A, B) and middle (C-F) region of the Dll4+/- 
and Dll4-/- embryos with 8.5 (A-D) and 9.25 dpc (E-H). (A-D) Dll4-/- arterial endothelial cells migrate (arrows in B and D) 
towards the dorso-lateral region of the neural tube. In the anterior region of the Dll4 null embryos, the aortic (a, β-galactosi-
dase+) cells migrate towards the developing anterior cardinal vein (v), before the onset of circulation (B). (E, F) At later stages, 
in the middle region of the embryo, this dorsal migration leads to the delocalization of the dorsal aortae. The main circulation 
in the mutant embryos occurs through two vessels that localize laterally (F) and not ventrally (E) to the neural tube. (G, H) In 
the anterior region of the later-stage Dll4-/- embryos the fusion (arrows) between the dorsal sprouting of the aortae (a) and the 
anterior cardinal veins (v) is evident. (Scale Bars: 50 μm).BMC Developmental Biology 2008, 8:117 http://www.biomedcentral.com/1471-213X/8/117
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(that will in turn express more Delta) and therefore will
acquire a different fate. This mechanism allows the differ-
entiation between initially equivalent cells.
To understand how the Notch pathway regulates endothe-
lial cell differentiation, we analysed endothelial cell
expression of Notch1, Dll4 and Hey1 in early development
of the arteries (dorsal aortae). In the initial stages of arte-
rial development, Dll4  expression is patchy and not
detected in all endothelial cells (data not shown). Some
hours later, its expression is present in almost all endothe-
lial cells of the dorsal aortae, although the level of expres-
sion differs from cell to cell. The expression of Notch1 and
the effector Hey1  is also found in almost all arterial
endothelial cells (Fig. 6A, B and 6C), which suggest that
these genes can be expressed in the same cells. To explore
this possibility, double in situ hybridization for Notch1
and Dll4 mRNA was carried out, showing that these genes
are indeed expressed at high levels in the same cell (Fig.
6D, E and 6F). These results indicate that Notch activation
in the arterial endothelium by Dll4 is likely to be induc-
tive rather than inhibitory. Notch1  expression is also
detected in the cardinal vein endothelium at early stages
(Fig. 6D), but here it is lower than in the dorsal aortae,
probably due to lack of Notch signalling induction by
Dll4. In fact, Hey1  expression was not detected in the
venous endothelium even at earlier stages of vein develop-
ment (data not shown). In Dll4-/- embryos, Notch1 expres-
sion was still detected in both veins and dorsal aortae, but
in these embryos the expression levels seem to be equal
between dorsal aortae and cardinal veins (Fig. 6G), sug-
gesting that there is always a basal level of Notch1 expres-
sion that is independent of Dll4, and that Dll4 further
induces Notch1 expression levels. Furthermore, there is a
basal expression of Dll4 that is independent of Notch1
activation, since the Dll4-lacZ reporter gene is still
expressed in Dll4-/- embryos in the absence of Hey1 expres-
sion (Fig. 6H, I).
Discussion
The initial steps of arterial morphogenesis require the
migration of endothelial precursors and their assembly
into lumenized vessels. Shortly after these vessels grow
and branch accordingly to the cues provided by the sur-
rounding tissues. Previous studies with Notch signalling
defective zebrafish and mouse embryos showed the
importance of the pathway in early arteriogenesis [11,31].
Here we show that the Notch ligand Dll4 regulates the
arterial calibre and lumen by modulating the endothelial
cell response to angiogenic factors like VEGF (Fig. 7).
The Dll4 gene is strongly expressed in the primordial arter-
ies and heart of early embryos and its complete loss of
function causes early and severe vascular defects [15]. As
disruption of heart morphogenesis in several mutants is
coincident with defects in vascular development, it is
sometimes difficult to discern if failure of perfusion led to
defective vascular development, or whether the vascular
developmental defect is an independent event. Further-
more, in the early embryo it has previously been shown
that blood flow can regulate the expression of some arte-
rial specific genes, like Efnb2 [21], which is not detected in
Dll4-/- arterial endothelial cells [15]. To clarify if the early
phenotype is caused by endothelial or cardiac/blood flow
defects, Dll4-/- embryos were analysed before the onset of
circulation. The results indicate that the arterial calibre
reduction in these mutants is already clear at 8 ss, thus
occurs earlier than the establishment of perfusion, and
therefore cannot be caused by impaired haemodynamic
forces but constitutes a primary vascular defect. This very
early remodelling defect suggested a role of Dll4 in early
vasculogenesis. However, the expression analysis of
Notch1, Dll4 and Hey1 in early embryos revealed that only
Notch1 can be expressed in angioblasts, which excludes
the involvement of the Dll4 ligand in the initial endothe-
lial cell differentiation from mesodermally derived cells.
Jagged1(Jag1) is another Notch ligand that is also
expressed in the early embryo arterial endothelium. Total
or endothelial specific Jag1 loss of function leads to
embryo death at 10.5 dpc [32,33], one day later than loss
of Notch1 or Dll4. Endothelial Jag1 mutants show defects
in the development of the arterial vascular smooth muscle
without having a decrease of Notch signalling in endothe-
lial cells [32]. Our results show that the Dll4-/- embryos
suffer severe arterial calibre reduction before the existence
of clearly differentiated smooth muscle cells (α-SMA+).
Furthermore the mutant aortas are surrounded by neural
crest derived smooth muscle cell progenitors (SM22α+),
some of which are associated with the reduced mutant
arterial endothelium. However these results do not
exclude a role of Dll4 in arterial smooth muscle develop-
ment at later stages of development.
The morphologic analysis of early (6–10 ss) dorsal aortae
shows that the arterial calibre of the Dll4-/- embryos is
much smaller than that of the wild-type, even though the
number of endothelial cells is only slightly reduced. In
addition, there is lack of a uniform laminin-rich basement
membrane under the endothelial cells and a defective
deposition of endothelial matrix proteins like collagenIV
and specially fibronectin. Thus the abnormal organiza-
tion of the mutant endothelial cells can be partially
explained by defects in the formation of a proper endothe-
lial basement membrane. These defects could be the result
of either reduced production or active degradation of the
basement membrane components. One of the most obvi-
ous consequences of this arterial cohesion defect is the
extensive haemorrhaging observed in these mutant
embryos upon the onset of blood flow. Interestingly, theBMC Developmental Biology 2008, 8:117 http://www.biomedcentral.com/1471-213X/8/117
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Higher expression of VEGFR-2 and Robo-4 but lower expression of Endoglin in Dll4-/- embryos Figure 5
Higher expression of VEGFR-2 and Robo-4 but lower expression of Endoglin in Dll4-/- embryos. (A) Relative quanti-
tative gene expression in Dll4-/- embryos compared to Dll4+/+ (n = 4 per group) show increased expression of VEGFR-2 and 
Robo-4 and lower expression of Endoglin in the Dll4-/- mutants. Values were normalized to those of β-actin. (B-D) In situ 
hybridization on 9.0 dpc embryos cryosections show upregulation of VEGFR-2 specifically in Dll4-/- dorsal aortae (a). (B) In a 
thick section (50 μm) of a Dll4+/- embryo strong expression of Dll4 can be observed on the dorsal aortae and intersomitic ves-
sels but no expression is detected on veins (v). (C) In a Dll4+/+ embryo VEGFR-2 is highly expressed in the veins and weakly 
expressed on the Dll4 expressing dorsal aortae. (D) In the absence of the arterial Dll4, VEGFR-2 is expressed at the same or at 
a higher level in the dorsal aortae compared to the anterior cardinal veins. (E, F) VEGFR1 (Flt1) in situ hybridization (in red) 
showing similar endothelial expression levels between control and mutant aortae (a) and umbilical arteries (ua). DAPI in blue. 
(G, H) Imunostaining for Endoglin (CD105) showing similar protein levels in endothelial cells of control and mutant embryos. 
Error bars represent st.dev. * indicates p < 0.05. (Scale Bars: 100 μm).BMC Developmental Biology 2008, 8:117 http://www.biomedcentral.com/1471-213X/8/117
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defect observed in the basement membrane occurs in
both the reduced and normal calibre regions of the Dll4-/-
dorsal aortae. This suggests that the arterial calibre reduc-
tion is not solely caused by a weaker and incomplete, and
thus permissive, basement membrane, although this may
influence the behaviour of endothelial cells in the pres-
ence of adequate angiogenic stimuli. In fact, the Dll4-/-
dorsal aortae present a normal calibre only in the presom-
itic region, where VEGF is produced exclusively by the
endoderm. In the anterior and middle somitic regions of
the embryo, VEGF is also produced by the neural tube and
somites, forming a concentration gradient within the
newly formed intersomitic spaces, and this difference in
VEGF production may underlie the difference in arterial
diameter between the anterior and posterior regions of the
embryo. Besides VEGF, other neural tube derived factors
like slits, semaphorins and netrins can attract endothelial
cells and be responsible for the correct alignment of the
dorsal aortae, since ablation of VEGF in the peripheral
nerves of the skin does not impair the co-alignment
between arteries and nerves [34].
The Dll4-/- aortic endothelial cells are likely to respond
more than their wild-type counterparts to the neural tube
or somite secreted factors, because they migrate earlier
and in higher numbers. Alternatively these mutant
endothelial cells could be less susceptible to the repulsive
factors produced in neural tube or somites. This is
unlikely, as vascular invasion of somites or neural tube
was not observed. Besides increased migration, the
mutant arterial endothelial cells have increased prolifera-
tion to nearly twice that of wild-type endothelial cells,
which further confirms the higher responsiveness of these
cells to local angiogenic factors. These results indicate that
the observed smaller arterial calibre and reduced number
of endothelial cells is caused by an active outward cell
Notch1 and Dll4 are expressed at different levels in different cells but at high levels in the same cell of the developing arteries Figure 6
Notch1 and Dll4 are expressed at different levels in different cells but at high levels in the same cell of the 
developing arteries. (A-C) In situ hybridization on consecutive cryosections of 8.75 dpc (12 ss) Dll4+/+ embryos showing that 
Notch1, Dll4 and Hey1 are expressed (red) in almost all aortic endothelial cells. (D-F) Double in situ hybridization for Notch1 
and Dll4 reveals that these genes are expressed at high levels in the same cells. Note also that Notch1 is weakly expressed on 
the anterior cardinal veins (v), where there is no expression of Dll4. (G-I) In the Dll4-/- embryos the Notch1 receptor is still 
expressed on dorsal aortae (da) but there is no detectable endothelial expression of the effector Hey1 (I), although its expres-
sion remains in the pericardium (p). (Scale Bars: 50 μm).BMC Developmental Biology 2008, 8:117 http://www.biomedcentral.com/1471-213X/8/117
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migration that overcomes the increase in arterial cell pro-
liferation. Previous in vitro studies with human endothe-
lial cells also demonstrated that Notch signalling
activation decreases endothelial cell proliferation [35,36].
Our in vivo findings are consistent with these observations
and suggest that Dll4 induced Notch signalling can be a
physiological inhibitor of endothelial cell proliferation,
allowing cells to differentiate and form an optimal vascu-
lar lumen.
The role of Notch signalling in early angiogenesis appears
therefore to be fundamentally different than that
described in Notch regulation of early neurogenesis, in
which a pool of non-committed neuroblasts is induced to
proliferate and prevented from differentiating by Notch
controlled lateral inhibition [37,38]. The in situ hybridiza-
tion data in the current study suggests that arterial
endothelial Notch signalling is inductive rather than
inhibitory because the Notch1 receptor and the Dll4 lig-
and are expressed at high levels in the same cell and
almost in all aortic endothelial cells. The in vivo activation
of Notch signalling in adult mouse arteries leads to
increased expression of the ligand Dll4, Notch receptors,
and downstream effectors such as bHLH transcription fac-
Regulation of arterial calibre and endothelial cell migration by Dll4 Figure 7
Regulation of arterial calibre and endothelial cell migration by Dll4. Model illustrating the difference in the behaviour 
of endothelial cells in the presence or absence of Notch signalling mediated by the Dll4 ligand in the early embryo arterial 
endothelium. The loss of Notch signalling leads to downregulation of arterial specific genes and upregulation of VEGFR-2 which 
may increase migration and proliferation of endothelial cells. The dorsal aortae (da) endothelial cells migrate towards the lat-
eral region of the neural tube (nt) or pre-formed veins (v) with which they fuse. In the Dll4+/+ embryos Notch signalling induces 
arterial endothelial cell differentiation and stabilization, as well as promoting the formation of a consistent basement membrane 
(bm).BMC Developmental Biology 2008, 8:117 http://www.biomedcentral.com/1471-213X/8/117
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tor Hey1, which supports the possibility that Notch sig-
nalling induces a positive loop in endothelial cells
resulting in induction of Notch receptor and its cognate
ligand [39]. Furthermore there is a basal level of Notch1
and Dll4 expression in arterial endothelial cells that is
independent of Notch-Dll4 signalling, since there is
expression of both the Dll4-lacZ reporter and Notch1 in
the Dll4-/- mutants.
The RT-PCR and in situ hybridization results obtained are
consistent with the observed mutant endothelial cell
behaviour. The Dll4-/- arterial endothelial cells express
more VEGFR-2 which is required for VEGF mediated
endothelial cell migration and proliferation [40]. This
direct relationship between VEGF signalling and the
Notch pathway was previously suggested by in vitro stud-
ies with HUVECs where Notch activation, through the
upregulation of Dll4, reduces the expression of VEGFR-2
and Nrp-1 [41,42]. The receptor Robo-4 is also upregu-
lated in the Dll4-/- embryos. At the stages analysed it is
expressed throughout the endothelial network and, like
VEGFR-2, it is further induced at sites of active angiogen-
esis. In vivo knockdown of Robo-4 in zebrafish embryos
suppresses the formation of intersomitic vessels due to
inhibition of endothelial cell sprouting and migration,
seen by time-lapse analysis [23], which is the opposite to
the phenotype observed in Dll4-/- mouse embryos. Robo-
4 also participates in attraction-guidance through Rho-
GTPases in vascular development, as Robo-4 gain of func-
tion experiments in vitro showed activation of Cdc42 and
Rac1 Rho-GTPases [26]. Therefore Robo-4 may be one of
the mediators of the increased migration of Dll4-/-
endothelial cells in response to its ligand Slit produced by
the somites and the neural tube. Interestingly, Robo-4 lev-
els decline in the Dll4 expressing dorsal aortae after 9.0
dpc [24] and in the mouse retina Robo-4 is not expressed
in the tip cells known to highly express Dll4 [28]. How-
ever, deletion of Robo-4 in the mouse is not lethal and
developmental angiogenesis occurs normally [28], sug-
gesting that its function might be compensated by other
genes. Nonetheless its loss of function enhances post-
natal induced pathologic angiogenesis and endothelial
permeability. This inhibition is thought to depend on
Slit2-Robo4 suppression of VEGF165-Src induced
endothelial migration and tube formation but not prolif-
eration [28]. Although controversial these results suggest
that Robo4 could act differently during development and
pathological angiogenesis. We also found a significant
reduction in the expression of the TGF-β1 co-receptor
endoglin. Eng-/- mutant embryos die around 10.5 dpc due
to several cardiovascular defects that also include abnor-
mal arterio-venous fusions, and this phenotype is inde-
pendent of loss of Efnb2 expression [30,43]. Furthermore,
in vitro studies show that Eng-/- endothelial cells have
increased proliferation [29].
The vessel response to angiogenic factors must be tightly
regulated to ensure a balance between the formation of
new sprouts and the remodelling of previously formed
vessels. Such regulation allows the formation of a hierar-
chical system of vessels with critical contribution from the
Notch-Dll4 pathway, which modulates VEGF signalling in
endothelial cells. An important example of this role has
been recently reported in relation to the vascularisation of
the retina in newborn mice [44-46].
We observed migration of Dll4-/- aortic endothelial cells
towards the developing anterior cardinal veins in the
dorso-lateral region of the neural tube (Fig. 7). This migra-
tion and delocalization of the "arterial" Dll4-/- endothelial
cells to the assembly region of the primordial veins may
be related to faulty differentiation [13,15,31,47] and
increased responsiveness to the angiogenic factors.
VEGF induces expression of Dll4 [48] which in turn, by
activating the Notch pathway, reduces endothelial cell
sensitivity and responsiveness to VEGF. We thus suggest
that the Notch pathway could constitute a negative feed-
back mechanism to ensure that the formation and exten-
sion of new arterial vessel branches occurs only after the
growth and stabilization of the preceding main arterial
vessels. Without Notch signalling the arterial endothelial
cells proliferate and migrate in an uncontrolled manner,
resulting in the formation of a vasculature that is not effi-
cient in blood distribution due to exaggerated branching
and extension of the preformed vessels. A number of
recent reports indicate that this is also the case during
tumour neoangiogenesis, with loss of Notch activation by
Dll4 resulting in an inefficient vascular bed due to a dis-
proportionate increase in vessel branching [49-51].
Conclusion
Many of the currently used anti- or pro-angiogenic thera-
pies were designed after important findings concerning
early mouse embryo vascular development. The present
data shows that activation of the Notch pathway by the
ligand Dll4 can regulate several different key steps in arte-
riogenesis through interaction with other important
endothelial signalling mechanisms. The understanding of
these interactions between different signalling pathways
offers alternatives for future therapeutic intervention.
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